Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 23%
Hold 31%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co is positioning itself for continued growth and success in the growing behavioral health marketplace, with a strong demand for its services and impressive organic growth through expansions and M&A. The company's recent earnings beat and raised guidance, along with its efforts to clean up its story and improve its cash flow profile, make it a positive investment opportunity. Our price target for the company is $31, reflecting its higher EBITDA estimates and its focus on improving fundamentals and unlocking earnings potential from ramping facilities.

Bears say

Acadia Healthcare Co is a behavioral healthcare company with a diverse portfolio of facilities and services that includes acute inpatient psychiatric facilities, specialty treatment facilities, and residential treatment centers. While the company has shown positive financial momentum with increased guidance and improved operating efficiency, there are still underlying concerns about the operating environment, including increased bad debt and denials. Additionally, there are uncertainties surrounding the impact of the pandemic on demand for behavioral health services in the future. As such, the financial analyst has a negative outlook on the stock, with a neutral rating and a price target of $30.00, reflecting the recent stock appreciation.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 23% recommend Buy, 31% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $29.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $29.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.